Company
Headquarters: Kunming, China
Employees: 1,905
CN¥19.40 Billion
CNY as of Jan. 1, 2025
US$2.66 Billion
| Company | Market Cap (USD) |
|---|---|
| Novo Nordisk | $622.07 B |
| Vertex Pharmaceuticals Incorporated | $113.24 B |
| CSL Limited | $95.75 B |
| Regeneron Pharmaceuticals, Inc. | $76.33 B |
| Marinomed Biotech AG | $56.13 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $689.42 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $487.54 B |
| Johnson & Johnson | $353.05 B |
| AbbVie | $301.60 B |
Yunnan Botanee Bio-Technology Group Co.LTD manufactures and sells skincare products in China. Its products type cover cleansers and makeup removers, face masks, toners, serums, moisturizers and creams, eye cream, sprays, sun care, foundations, and body cares. The company was founded in 2010 and is based in Kunming, China.
| Last Financial Reports Date | Sept. 30, 2024 |
| Revenue TTM | CN¥6.11 B |
| EBITDA | CN¥1.06 B |
| Gross Profit TTM | CN¥4.08 B |
| Profit Margin | 9.70% |
| Operating Margin | -6.20% |
| Quarterly Revenue Growth | 14.00% |
Yunnan Botanee Bio-Technology Group Co.LTD has the following listings and related stock indices.
Stock: SZSE: 300957 wb_incandescent